As a thriving pharmaceutical company, Protheragen Inc. ("Protheragen") focuses on acquiring, developing and commercializing novel pharmaceutical and biotechnology products for both therapeutic purposes and diagnostic applications. Guided by our advanced business strategy – the “VIC R&D model”: V (risk investment), I (IP right) and C (CRO), we are dedicated to making drug discovery and development activities the most effective via a collection of efforts and advantages from all agencies. Our streamlined management structure and rich trading experience allow us to seize opportunities that may elapse in a second and enable us to select from a series of options the best corporate or financial structure so as to successfully develop each product candidate. We believe drug development surely will be accelerated by combining Protheragen's skills and expertise.